Prioritizing symptom management in the treatment of chronic heart failure

由 Koshy, Aaron O., Gallivan, Elisha R., McGinlay, Melanie, Straw, Sam, Drozd, Michael, Toms, Anet G., Gierula, John, Cubbon, Richard M., Kearney, Mark T., Witte, Klaus K.
發表在 ESC Heart Fail (2020)

Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction

由 Straw, Sam, McGinlay, Melanie, Relton, Samuel D., Koshy, Aaron O., Gierula, John, Paton, Maria F., Drozd, Michael, Lowry, Judith E, Cole, Charlotte, Cubbon, Richard M, Witte, Klaus K., Kearney, Mark T.
發表在 ESC Heart Fail (2020)

Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data

由 Straw, Sam, McGinlay, Melanie, Drozd, Michael, Slater, Thomas A., Cowley, Alice, Kamalathasan, Stephe, Maxwell, Nicholas, Bird, Rory A., Koshy, Aaron O., Prica, Milos, Patel, Peysh A., Relton, Samuel D., Gierula, John, Cubbon, Richard M., Kearney, Mark T., Witte, Klaus K.
發表在 BMC Palliat Care (2021)

Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy

由 Caspi, Talia, Straw, Sam, Cheng, Chew, Garnham, Jack O, Scragg, Jason L., Smith, Jessica, Koshy, Aaron O., Levelt, Eylem, Sukumar, Piruthivi, Gierula, John, Beech, David J., Kearney, Mark T., Cubbon, Richard M., Wheatcroft, Stephen B., Witte, Klaus K., Roberts, Lee D., Bowen, T. Scott
發表在 J Am Heart Assoc (2020)